Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

Clinical trial NCT05480449 · RECRUITING

Trial details

NCT number: NCT05480449
Sponsor: Stephan Grupp MD PhD
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B Cell Acute Lymphoblastic Leukemia (B-ALL)B Lineage Lymphoblastic Lymphoma

Start date: 2022-09-20
Primary completion: 2027-09-20
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.